Genmab A (GMAB) Raw Materials (2023 - 2025)

Genmab A's Raw Materials history spans 3 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 500.0% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $6.0 million, up 500.0%, while the annual FY2025 figure was $6.0 million, 500.0% up from the prior year.
  • Raw Materials reached $6.0 million in Q4 2025 per GMAB's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $6.0 million in Q4 2025 to a low of $1.0 million in Q4 2024.
  • Average Raw Materials over 3 years is $3.0 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Raw Materials: tumbled 50.0% in 2024, then skyrocketed 500.0% in 2025.
  • A 3-year view of Raw Materials shows it stood at $2.0 million in 2023, then crashed by 50.0% to $1.0 million in 2024, then surged by 500.0% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Raw Materials are $6.0 million (Q4 2025), $1.0 million (Q4 2024), and $2.0 million (Q4 2023).